Medicare Enrolled
Steven Yablon
Nephrology · West Nyack, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Yablon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Yablon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Yablon
Steven Yablon is a nephrology specialist in West Nyack, NY, with 20 years of NPI registration. Based on federal Medicare data, Yablon performed 2,610 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Yablon received a total of $12,479 from 56 pharmaceutical and/or device companies across 586 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Yablon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 16% volume in NY
$12,479 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,610
Medicare services
Top 16% in NY for nephrology
Not available
Unique patients (not deduplicated)
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
726 | $108 | $536 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
649 | $4 | $52 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
374 | $8 | $22 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
351 | $74 | $264 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
86 | $322 | $1,526 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
66 | $66 | $871 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
65 | $111 | $383 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
46 | $36 | $74 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
44 | $72 | $96 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
39 | $162 | $748 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $144 | $768 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
28 | $169 | $767 |
| New patient office visit, complex (60-74 min) | 25 | $186 | $1,071 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
22 | $264 | $1,166 |
| Hemodialysis procedure requiring repeated evaluation A hemodialysis treatment that involves repeated evaluation during the procedure. |
19 | $93 | $1,363 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $69 | $414 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
17 | $193 | $613 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$12,479
Total received (2018-2024)
Avg $1,783/year across 7 years
Top 10% in NY for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
586
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,328
2023
$2,800
2022
$2,463
2021
$1,618
2020
$1,009
2019
$927
2018
$1,335
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$378
Boehringer Ingelheim Pharmaceuticals, Inc.
$365
Novartis Pharmaceuticals Corporation
$254
Vifor Pharma, Inc.
$145
Bayer Healthcare Pharmaceuticals Inc.
$128
Amgen Inc.
$121
Travere Therapeutics, Inc.
$118
PFIZER INC.
$86
Cycle Pharmaceuticals Inc
$78
Fresenius USA Marketing, Inc.
$73
Alnylam Pharmaceuticals Inc.
$67
CALLIDITAS THERAPEUTICS US INC.
$62
Lilly USA, LLC
$60
Novo Nordisk Inc
$57
ANI Pharmaceuticals, Inc.
$54
SCPHARMACEUTICALS INC.
$51
Kyowa Kirin, Inc.
$50
Aurinia Pharma U.S., Inc.
$50
GlaxoSmithKline, LLC.
$28
Otsuka America Pharmaceutical, Inc.
$26
Mallinckrodt Hospital Products Inc.
$23
OPKO Pharmaceuticals, LLC
$21
GENZYME CORPORATION
$17
Ardelyx, Inc.
$15
Top 3 companies account for 42.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,050
Amgen Inc.
$792
Boehringer Ingelheim Pharmaceuticals, Inc.
$686
Vifor Pharma, Inc.
$638
OPKO Pharmaceuticals, LLC
$569
Otsuka America Pharmaceutical, Inc.
$433
Aurinia Pharma U.S., Inc.
$403
Novo Nordisk Inc
$400
Mallinckrodt Hospital Products Inc.
$368
GlaxoSmithKline, LLC.
$327
Travere Therapeutics, Inc.
$319
Novartis Pharmaceuticals Corporation
$314
Fresenius USA Marketing, Inc.
$309
Mallinckrodt LLC
$307
Daiichi Sankyo Inc.
$298
Calliditas Therapeutics US Inc.
$298
Relypsa, Inc.
$294
Bayer HealthCare Pharmaceuticals Inc.
$274
Bayer Healthcare Pharmaceuticals Inc.
$261
Amarin Pharma Inc.
$250
PFIZER INC.
$241
Kowa Pharmaceuticals America, Inc.
$236
GENZYME CORPORATION
$232
ANI Pharmaceuticals, Inc.
$193
Mallinckrodt Enterprises LLC
$161
W. L. Gore & Associates, Inc.
$140
Horizon Therapeutics plc
$131
Boston Scientific Corporation
$124
Cumberland Pharmaceuticals, Inc.
$123
Alnylam Pharmaceuticals Inc.
$120
Alexion Pharmaceuticals, Inc.
$110
AKEBIA THERAPEUTICS INC
$83
CALLIDITAS THERAPEUTICS US INC.
$82
Welch Allyn
$79
Cycle Pharmaceuticals Inc
$78
Kyowa Kirin, Inc.
$75
Keryx Biopharmaceuticals, Inc.
$72
Exeltis, USA Inc.
$61
Lilly USA, LLC
$60
SCPHARMACEUTICALS INC.
$51
Regeneron Healthcare Solutions, Inc.
$47
ARBOR PHARMACEUTICALS, INC.
$46
Takeda Pharmaceuticals U.S.A., Inc.
$41
Retrophin, Inc.
$38
Merck Sharp & Dohme LLC
$37
Janssen Pharmaceuticals, Inc
$32
ABBVIE INC.
$27
SANOFI PASTEUR INC.
$21
Horizon Pharma plc
$21
Ultragenyx Pharmaceutical Inc.
$21
AMAG Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme Corporation
$20
Allergan Inc.
$19
Genentech USA, Inc.
$18
Otsuka Pharmaceutical Development & Commercialization, Inc.
$16
Ardelyx, Inc.
$15
Top 3 companies account for 28.3% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ACTHAR · AURYXIA · Auryxia · BENLYSTA · BYSTOLIC · Crysvita · DIFICID · ENTRESTO · EVUSHELD · Edarbi · FABRAZYME · FABRY-DISEASE · FARXIGA · FERAHEME · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FUROSCIX · Fabhalta · GATTEX · GIVLAARI · GORE VIABAHN Endoprosthesis · IBSRELA · INJECTAFER · INVOKANA · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · LEQVIO · LOKELMA · LUPKYNIS · Livalo · MAVYRET · OXLUMO · Ozempic · PRALUENT ALIROCUMAB INJECTION · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Parsabiv · Prolia · RAYALDEE · RYBELSUS · Rayaldee · Rayaldee (old) · Repatha · Rituxan · Rybelsus · SAMSCA · SHINGRIX · SOLIRIS · TARPEYO · TAVNEOS · TERLIVAZ · TRADJENTA · Tavneos · Thiola · Tiopronin · ULTOMIRIS · Ultomiris · VERQUVO · VPRIV · Vaprisol · Vascepa · Velphoro · Veltassa
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Nephrologists in nearby ZIP areas
430
County median income
$110,631
Nearest hospital to ZIP centroid (approximate)
NYACK HOSPITAL
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Yablon is a clinical cardiology specialist, with above-average Medicare volume (top 16% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Yablon experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Yablon performed 726 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Yablon receive payments from pharmaceutical companies?
Yes. Yablon received a total of $12,479 from 56 companies across 586 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Yablon's costs compare to other nephrologists in West Nyack?
Yablon's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Yablon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in West Nyack
Browse nephrologists in West Nyack ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in NY
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in NY
Which NY nephrologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology